Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel TAP Block in Colorectal Surgery
NCT04781075Phase 4Completed
- Sponsor
- Ochsner Clinic Foundation
- Start
- Dec 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Ochsner Clinic Foundation. Primary endpoint: Maximum Daily Pain Scale. Started Dec 2017; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04781075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04781075.